PLIANT THERAPEUTICS, INC.
Total Trades
63
Buys
0
Sells
46
Largest Trade
N/A
Insiders
7
Institutional Funds
69
Inst. Value
$1M+
Activist Filings
42
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Cummings Keith Lamont | CFO | SELL | $15K–$50K | 24K | $1.28 | Jan 23, 2026 |
| Cheung Lily | Chief Human Resour… | SELL | $1K–$15K | 8K | $1.28 | Jan 23, 2026 |
| Coulie Bernard | President and CEO | SELL | $100K–$500K | 89K | $1.28 | Jan 23, 2026 |
| Kuo Minnie | COO | SELL | $1K–$15K | 7K | $1.28 | Jan 23, 2026 |
| Coulie Bernard | President and CEO | SELL | $500K+ | 52K | $11.20 | Jan 22, 2025 |
| Cummings Keith Lamont | CFO | SELL | $100K–$500K | 20K | $11.20 | Jan 22, 2025 |
| Hull Hans | Chief Business Off… | SELL | $100K–$500K | 16K | $11.20 | Jan 22, 2025 |
| Lefebvre Eric | Chief Medical Offi… | SELL | $100K–$500K | 18K | $11.20 | Jan 22, 2025 |
| Cheung Lily | Chief Human Resour… | SELL | $15K–$50K | 4K | $11.20 | Jan 22, 2025 |
| Ouimette Mike | General Counsel & … | SELL | $100K–$500K | 24K | $11.11 | Jan 22, 2025 |
| Cummings Keith Lamont | CFO | SELL | $100K–$500K | 10K | $17.23 | Jan 19, 2024 |
| Hull Hans | Chief Business Off… | SELL | $100K–$500K | 10K | $17.23 | Jan 19, 2024 |
| Coulie Bernard | President and CEO | SELL | $100K–$500K | 26K | $17.23 | Jan 19, 2024 |
| Lefebvre Eric | Chief Medical Offi… | SELL | $100K–$500K | 10K | $17.23 | Jan 19, 2024 |
| Ouimette Mike | General Counsel & … | SELL | $50K–$100K | 5K | $17.23 | Jan 19, 2024 |
| Hull Hans | Chief Business Off… | EXERCISE | $15K–$50K | 11K | $2.08 | Aug 8, 2023 |
| Hull Hans | Chief Business Off… | SELL | $500K+ | 35K | $20.01 | Aug 8, 2023 |
| Ouimette Mike | General Counsel & … | SELL | $50K–$100K | 5K | $17.55 | Jul 21, 2023 |
| Ouimette Mike | General Counsel & … | SELL | $100K–$500K | 13K | $18.01 | Jul 20, 2023 |
| Lefebvre Eric | Chief Medical Offi… | SELL | $100K–$500K | 22K | $18.01 | Jul 20, 2023 |
| Hull Hans | Chief Business Off… | SELL | $100K–$500K | 18K | $18.01 | Jul 20, 2023 |
| Cummings Keith Lamont | CFO | SELL | $100K–$500K | 20K | $18.01 | Jul 20, 2023 |
| Coulie Bernard | President and CEO | SELL | $1M+ | 70K | $18.01 | Jul 20, 2023 |
| Ouimette Mike | General Counsel & … | SELL | $100K–$500K | 8K | $26.62 | Apr 3, 2023 |
| Lefebvre Eric | Chief Medical Offi… | SELL | $100K–$500K | 11K | $26.52 | Apr 3, 2023 |
| Hull Hans | Chief Business Off… | SELL | $100K–$500K | 9K | $26.52 | Apr 3, 2023 |
| Cummings Keith Lamont | CFO | SELL | $100K–$500K | 10K | $26.52 | Apr 3, 2023 |
| Coulie Bernard | President and CEO | SELL | $500K+ | 35K | $26.52 | Apr 3, 2023 |
| Coulie Bernard | President and CEO | SELL | $1M+ | 30K | $33.91 | Feb 6, 2023 |
| Coulie Bernard | President and CEO | EXERCISE | $100K–$500K | 30K | $6.22 | Feb 6, 2023 |
| Coulie Bernard | President and CEO | SELL | $1M+ | 45K | $34.48 | Feb 2, 2023 |
| Coulie Bernard | President and CEO | EXERCISE | $100K–$500K | 45K | $3.87 | Feb 2, 2023 |
| Coulie Bernard | President and CEO | GRANT | N/A | 146K | — | Jan 28, 2023 |
| Coulie Bernard | President and CEO | EXERCISE | $50K–$100K | 30K | $2.08 | Jan 28, 2023 |
| Coulie Bernard | President and CEO | SELL | $1M+ | 55K | $35.32 | Jan 28, 2023 |
| Coulie Bernard | President and CEO | EXERCISE | $50K–$100K | 45K | $2.08 | Jan 26, 2023 |
| Coulie Bernard | President and CEO | SELL | $1M+ | 60K | $33.12 | Jan 26, 2023 |
| Ouimette Mike | General Counsel & … | EXERCISE | $100K–$500K | 20K | $18.09 | Jan 26, 2023 |
| Ouimette Mike | General Counsel & … | SELL | $500K+ | 20K | $34.19 | Jan 26, 2023 |
| Lefebvre Eric | Chief Medical Offi… | SELL | $1M+ | 68K | $34.48 | Jan 26, 2023 |
| Cummings Keith Lamont | CFO | EXERCISE | $100K–$500K | 30K | $4.50 | Jan 26, 2023 |
| Cummings Keith Lamont | CFO | SELL | $1M+ | 30K | $35.00 | Jan 26, 2023 |
| Coulie Bernard | President and CEO | SELL | $100K–$500K | 20K | $19.07 | Jan 10, 2023 |
| Coulie Bernard | President and CEO | EXERCISE | $15K–$50K | 20K | $2.08 | Jan 10, 2023 |
| Coulie Bernard | President and CEO | SELL | $500K+ | 30K | $19.20 | Jan 6, 2023 |
| Coulie Bernard | President and CEO | EXERCISE | $50K–$100K | 30K | $2.08 | Jan 6, 2023 |
| Ouimette Mike | General Counsel & … | SELL | $50K–$100K | 3K | $19.38 | Dec 23, 2022 |
| Cummings Keith Lamont | CFO | GRANT | N/A | 19K | — | Dec 22, 2022 |
| Cummings Keith Lamont | CFO | SELL | $100K–$500K | 10K | $19.10 | Dec 22, 2022 |
| Coulie Bernard | President and CEO | GRANT | N/A | 69K | — | Dec 22, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 69 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 6.1M | $1M+ | SH |
| Blue Owl Capital Holdings LP | 3.0M | $1M+ | SH |
| Blue Owl Capital Holdings LP | 3.0M | $1M+ | SH |
| ACADIAN ASSET MANAGEMENT LLC | 2.4M | $1M+ | SH |
| Monaco Asset Management SAM | 1.9M | $1M+ | SH |
| Redmile Group, LLC | 1.6M | $1M+ | SH |
| Prosight Management, LP | 1.6M | $1M+ | SH |
| BML Capital Management, LLC | 1.5M | $1M+ | SH |
| UBS Group AG | 1.1M | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 1.0M | $1M+ | SH |
| Centiva Capital, LP | 1.0M | $1M+ | SH |
| Peapod Lane Capital LLC | 886K | $1M+ | SH |
| GSA CAPITAL PARTNERS LLP | 624K | $500K+ | SH |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 557K | $500K+ | SH |
| BESSEMER GROUP INC | 527K | $500K+ | SH |
| DekaBank Deutsche Girozentrale | 40K | $500K+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 481K | $500K+ | SH |
| Connor, Clark & Lunn Investment Management Ltd. | 372K | $100K–$500K | SH |
| TORNO CAPITAL, LLC | 320K | $100K–$500K | SH |
| ArrowMark Colorado Holdings LLC | 281K | $100K–$500K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Point72 Asset Management, L.P.
SC 13G/A · Feb 17, 2026
0.1%
47K shares
SC 13G/A · Feb 17, 2026
3.3%
2.0M shares
SC 13G · Feb 9, 2026
3.4%
2.1M shares
SC 13G · Jan 31, 2026
3.4%
2.1M shares
SC 13G · Jan 23, 2026
3.4%
2.1M shares
SC 13G/A · Jan 8, 2026
0.9%
545K shares
SC 13G · Nov 14, 2025
7.3%
4.5M shares
SC 13G/A · Nov 14, 2025
0.0%
0 shares
Point72 Asset Management, L.P.
SC 13G · Sep 4, 2025
6.7%
4.1M shares
SC 13G/A · Aug 14, 2025
6.4%
3.9M shares
SC 13G · Aug 6, 2025
6.1%
3.7M shares
SC 13G/A · Jul 29, 2025
4.9%
3.0M shares
SC 13G/A · Jul 18, 2025
3.4%
2.1M shares
Paradigm BioCapital Advisors LP
SC 13G/A · May 15, 2025
0.0%
0 shares
T. Rowe Price Associates, Inc.
SC 13G/A · May 14, 2025
0.1%
88K shares
SC 13D · Mar 10, 2025
9.6%
5.9M shares
SC 13G/A · Mar 7, 2025
0.2%
132K shares
SC 13G/A · Feb 15, 2025
4.8%
2.9M shares
SC 13G · Nov 15, 2024
5.3%
3.2M shares
SC 13G/A · Nov 14, 2024
4.9%
3.0M shares
First Light Asset Management, LLC 46-3521994
SC 13G/A · Nov 14, 2024
3.1%
1.9M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Nov 14, 2024
8.0%
4.8M shares
Laurion Capital Management LP 56-2504425
SC 13G/A · Nov 12, 2024
0.0%
0 shares
PLIANT THERAPEUTICS, INC. (Subject)
SC 13G · Oct 4, 2024
0.0%
0 shares
SC 13G · Feb 15, 2024
5.0%
3.0M shares
First Light Asset Management, LLC 46-3521994
SC 13G · Feb 14, 2024
6.1%
3.6M shares
SC 13G/A · Feb 14, 2024
4.5%
2.7M shares
SC 13G/A · Feb 14, 2024
0.6%
339K shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G · Feb 14, 2024
6.3%
3.8M shares
SC 13G/A · Feb 14, 2024
9.6%
5.8M shares
The Vanguard Group - 23-1945930
SC 13G · Feb 13, 2024
5.1%
3.1M shares
SC 13G · Jan 25, 2024
8.0%
4.8M shares
SC 13G · Mar 20, 2023
5.3%
3.1M shares
SC 13G/A · Feb 14, 2023
8.0%
3.9M shares
SC 13G/A · Feb 14, 2023
3.8%
1.8M shares
SC 13G/A · Feb 13, 2023
6.6%
3.2M shares
Novartis Institutes for BioMedical Research, Inc.
SC 13G/A · Aug 31, 2022
4.4%
2.2M shares
SC 13G/A · Aug 10, 2022
12.6%
6.1M shares
SC 13G/A · Jun 10, 2022
9.6%
3.5M shares
SC 13G/A · Feb 14, 2022
8.6%
3.1M shares
Eventide Asset Management, LLC
SC 13G/A · Feb 14, 2022
0.1%
42K shares
SC 13G/A · Feb 11, 2022
7.1%
2.6M shares